Provided by Tiger Trade Technology Pte. Ltd.

Viatris Inc.

16.40
-0.1000-0.61%
Volume:835.76K
Turnover:13.72M
Market Cap:18.84B
PE:-46.28
High:16.51
Open:16.50
Low:16.34
Close:16.50
52wk High:18.39
52wk Low:9.43
Shares:1.15B
Float Shares:1.14B
Volume Ratio:1.67
T/O Rate:0.07%
Dividend:0.48
Dividend Rate:2.93%
EPS(TTM):-0.3543
EPS(LYR):-3.0024
ROE:-2.75%
ROA:2.67%
PB:1.32
PE(LYR):-5.46

Loading ...

India's Biocon Gains After Block Deal

Reuters
·
Jul 14

INDIA Stocks-indian Shares Set to Open Lower as Middle East Tensions Raise Inflation Worries

Reuters
·
Jul 14

Viatris Inc. Stock Falls Thursday, Underperforms Market

Dow Jones
·
Jul 10

Viatris Inc. Stock Falls Wednesday, Underperforms Market

Dow Jones
·
Jul 09

Drug Pricing Pressure Puts GSK And Global Pharma Stocks In Focus

Simply Wall St.
·
Jul 07

Viatris Inc. Stock Rises Thursday, Outperforms Market

Dow Jones
·
Jul 03

Viatris Refinances $247.7 Million Term Loan

MT Newswires Live
·
Jul 02

Viatris - Enters Amended and Restated Term Loan Credit Agreement on July 1, 2026 - SEC Filing

THOMSON REUTERS
·
Jul 02

Viatris - Secures ¥40 Bln Senior Unsecured Term Loan Facility - SEC Filing

THOMSON REUTERS
·
Jul 02

Viatris Enters Amended ¥40 Billion Term Loan Credit Agreement with Mizuho Bank-led Lenders

Reuters
·
Jul 02

The Bull Case For Viatris (VTRS) Could Change Following Positive Japan Phase 3 Data For VR-205

Simply Wall St.
·
Jul 01

Viatris Schedules Second-quarter 2026 Earnings Report and Conference Call

Reuters
·
Jul 01

Viatris Inc. Stock Falls Tuesday, Underperforms Market

Dow Jones
·
Jul 01

Viatris Says Phase 3 Japan Trial of Vr-205 in Iga Nephropathy Meets Primary Endpoint with 33.75% UPCR Drop

Reuters
·
Jun 29

Viatris - Targets Japanese Nda Submission for Vr-205 by End of 2026

THOMSON REUTERS
·
Jun 29

Viatris - Vr-205 Meets Primary and Key Secondary Endpoints and is Well Tolerated

THOMSON REUTERS
·
Jun 29

Viatris Announces Positive Top-line Results from Phase 3 Study of Vr-205 in Japanese Adults with Primary Immunoglobulin a Nephropathy

THOMSON REUTERS
·
Jun 29

Viatris - Vr-205 Shows 33.75% Reduction in Upcr at 9 Months in Phase 3 Study

THOMSON REUTERS
·
Jun 29

Viatris Inc. Stock Rises Friday, Outperforms Market

Dow Jones
·
Jun 27

Viatris Interim CFO Paul Campbell Sells 50,076 Shares for $809,927.6

Reuters
·
Jun 27